Beta-oxidation is the mitochondrial metabolic pathway that breaks down fatty acids into acetyl-CoA units through sequential removal of two-carbon fragments, generating NADH, FADH2, and acetyl-CoA for ATP production via the electron transport chain and TCA cycle.
graph TD
subgraph "Fatty Acid Activation & Transport"
FA["[Fatty acids](/en/fatty-acids)<br/>(cytoplasm)"]
ACS["Acyl-CoA Synthetase<br/>→ Fatty Acyl-CoA"]
CPT1["[CPT1](/en/cpt1)<br/>(rate-limiting)<br/>Outer membrane"]
CARN["[Carnitine](/en/carnitine) Shuttle<br/>(Acylcarnitine)"]
CPT2["CPT2<br/>Inner membrane<br/>→ Fatty Acyl-CoA"]
end
subgraph "β-Oxidation Spiral (Mitochondrial Matrix)"
ST1["❶ Acyl-CoA Dehydrogenase<br/>→ FADH2"]
ST2["❷ Enoyl-CoA Hydratase<br/>(Hydration, +H₂O)"]
ST3["❸ 3-Hydroxyacyl-CoA<br/>Dehydrogenase<br/>→ NADH"]
ST4["❹ Thiolase<br/>(Thiolytic cleavage)"]
ACOA["[Acetyl-CoA](/en/acetyl-coa)<br/>(2C released)"]
SHORT["Shortened Acyl-CoA<br/>(−2C)"]
end
subgraph "Energy Output"
TCA["[TCA cycle](/en/pathways/tca-cycle.md)"]
ETC["[Electron transport chain](/en/electron-transport-chain)"]
ATP["[ATP](/en/concepts/atp.md)<br/>(~106 per palmitate)"]
end
FA --> ACS
ACS --> CPT1
CPT1 --> CARN
CARN --> CPT2
CPT2 --> ST1
ST1 --> ST2
ST2 --> ST3
ST3 --> ST4
ST4 --> ACOA
ST4 --> SHORT
SHORT -->|"Repeat cycle<br/>(−2C each turn)"| ST1
ACOA --> TCA
TCA --> ETC
ETC --> ATP
style FA fill:#f8d7da,stroke:#dc3545
style ACS fill:#cce5ff,stroke:#004085
style CPT1 fill:#fff3cd,stroke:#ffc107
style CARN fill:#cce5ff,stroke:#004085
style CPT2 fill:#cce5ff,stroke:#004085
style ST1 fill:#cce5ff,stroke:#004085
style ST2 fill:#cce5ff,stroke:#004085
style ST3 fill:#cce5ff,stroke:#004085
style ST4 fill:#cce5ff,stroke:#004085
style ACOA fill:#d4edda,stroke:#28a745
style SHORT fill:#fff3cd,stroke:#ffc107
style TCA fill:#d4edda,stroke:#28a745
style ETC fill:#d4edda,stroke:#28a745
style ATP fill:#d4edda,stroke:#28a745
graph TD
subgraph "Regulation of β-Oxidation"
direction TB
subgraph "Activators"
FAST["[Fasting](/en/fasting)"]
EXER["[Exercise](/en/concepts/exercise.md)<br/>(aerobic)"]
SCFA["[SCFAs](/en/concepts/short-chain-fatty-acids.md)"]
AMPK["[AMPK](/en/ampk) Activation"]
end
subgraph "Inhibitors"
MAL["Malonyl-CoA<br/>(fed state signal)"]
INFL["[Chronic inflammation](/en/chronic-inflammation)<br/>([TNF-α](/en/concepts/tnf-alpha.md), [IL-6](/en/concepts/il-6.md))"]
DYSB["[Dysbiosis](/en/dysbiosis)<br/>(↓ SCFA production)"]
end
CPT1R["[CPT1](/en/cpt1)<br/>(gateway enzyme)"]
FLEX["[Metabolic flexibility](/en/concepts/metabolic-flexibility.md)"]
INFLEX["Metabolic Inflexibility<br/>→ [Insulin resistance](/en/insulin-resistance)<br/>→ [Metabolic syndrome](/en/metabolic-syndrome)"]
end
FAST -->|"activates"| AMPK
EXER -->|"activates"| AMPK
SCFA -->|"upregulates"| CPT1R
AMPK -->|"inhibits malonyl-CoA<br/>synthesis"| CPT1R
CPT1R -->|"active"| FLEX
MAL -->|"inhibits"| CPT1R
INFL -->|"inhibits"| CPT1R
DYSB -->|"reduces SCFAs"| CPT1R
CPT1R -->|"impaired"| INFLEX
style FAST fill:#d4edda,stroke:#28a745
style EXER fill:#d4edda,stroke:#28a745
style SCFA fill:#d4edda,stroke:#28a745
style AMPK fill:#d4edda,stroke:#28a745
style MAL fill:#f8d7da,stroke:#dc3545
style INFL fill:#f8d7da,stroke:#dc3545
style DYSB fill:#f8d7da,stroke:#dc3545
style CPT1R fill:#fff3cd,stroke:#ffc107
style FLEX fill:#d4edda,stroke:#28a745
style INFLEX fill:#f8d7da,stroke:#dc3545
Per cycle yield: 1 FADH2 + 1 NADH + 1 Acetyl-CoA. Palmitate (16C) undergoes 7 cycles → 8 Acetyl-CoA, 7 FADH2, 7 NADH → ~106 ATP.
Fatty acids are transported into mitochondria via the carnitine shuttle (CPT1 as rate-limiting enzyme). Inside the mitochondrial matrix, beta-oxidation proceeds in four repeating steps: (1) Oxidation by acyl-CoA dehydrogenase (producing FADH2), (2) Hydration, (3) Oxidation by 3-hydroxyacyl-CoA dehydrogenase (producing NADH), (4) Thiolytic cleavage by thiolase (releasing acetyl-CoA). Each cycle shortens the fatty acid by two carbons. Acetyl-CoA enters the TCA cycle for further oxidation. NADH and FADH2 donate electrons to the electron transport chain for ATP synthesis. In the fasted state or during aerobic exercise, beta-oxidation becomes the primary energy source for muscle, heart, and liver.
Beta-oxidation capacity determines metabolic flexibility—the ability to switch fuel sources from glucose to fat. Loss of beta-oxidation capacity (metabolic inflexibility) is a hallmark of insulin resistance, type 2 diabetes, and chronic disease. Dysbiosis reduces SCFA production, which normally signals intestinal mucosa and muscles to maintain beta-oxidation capacity. Chronic inflammation (via TNF-α and IL-6) inhibits CPT1 and beta-oxidation, forcing cells toward glucose dependence and contributing to metabolic syndrome. Exercise, fasting, and SCFAs upregulate beta-oxidation enzymes, restoring metabolic flexibility and insulin sensitivity.
- Occurs in mitochondrial matrix after fatty acid transport via carnitine shuttle
- CPT1 is rate-limiting enzyme for fatty acid entry into mitochondria
- Produces 1 FADH2, 1 NADH, and 1 acetyl-CoA per cycle
- 16-carbon palmitic acid yields 8 acetyl-CoA, 7 FADH2, 7 NADH = ~106 ATP
- Primary energy source during fasting and aerobic exercise
- Inhibited by malonyl-CoA (fed state signal)
- Upregulated by SCFAs, exercise, fasting, and AMPK activation
- Downregulated by chronic inflammation (TNF-α, IL-6)
- Loss of capacity defines metabolic inflexibility
- fatty acids — substrate broken down via beta-oxidation
- acetyl-CoA — product released with each two-carbon cleavage
- mitochondria — cellular organelle where beta-oxidation occurs
- carnitine — transport molecule required for fatty acid entry into mitochondria
- CPT1 — rate-limiting enzyme for mitochondrial fatty acid uptake
- FADH2 — electron carrier produced in first oxidation step
- NADH — electron carrier produced in second oxidation step
- TCA cycle — metabolic pathway that oxidizes acetyl-CoA from beta-oxidation
- electron transport chain — uses FADH2 and NADH from beta-oxidation for ATP synthesis
- metabolic flexibility — capacity for beta-oxidation determines fuel-switching ability
- insulin resistance — characterized by impaired beta-oxidation capacity
- short-chain fatty acids — SCFAs signal gut and muscle to maintain beta-oxidation
- dysbiosis — reduces SCFA production, impairing beta-oxidation signaling
- chronic inflammation — inhibits beta-oxidation via TNF-α and IL-6
- fasting — metabolic state that maximally activates beta-oxidation
- exercise — stimulus that upregulates beta-oxidation enzymes
- AMPK — master metabolic regulator that activates beta-oxidation
- ketogenesis — pathway that uses excess acetyl-CoA from beta-oxidation
- skeletal muscle — major tissue utilizing beta-oxidation for fuel
- metabolic syndrome — condition characterized by impaired beta-oxidation
- Module 3
- Module 5
- Module 6
- Module 7
- Module 8